Gevo Inc
NASDAQ:GEVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gevo Inc
NASDAQ:GEVO
|
US |
|
Citius Pharmaceuticals Inc
NASDAQ:CTXR
|
US |
|
E
|
Elemental Royalties Corp
OTC:ELEMF
|
CA |
|
Carbios SA
OTC:COOSF
|
FR |
|
P
|
Pearson PLC
DUS:PES
|
UK |
|
Ki-Star Real Estate Co Ltd
TSE:3465
|
JP |
|
Scholar Rock Holding Corp
NASDAQ:SRRK
|
US |
|
Marvel Discovery Corp
XTSX:MARV
|
CA |
Wall St Price Targets
GEVO Price Targets Summary
Gevo Inc
According to Wall Street analysts, the average 1-year price target for GEVO is 5.3 USD with a low forecast of 2.02 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GEVO's stock price target?
Price Target
5.3
USD
According to Wall Street analysts, the average 1-year price target for GEVO is 5.3 USD with a low forecast of 2.02 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Gevo Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Gevo Inc?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 3 years is 0%.
